Catheter Precision, Inc. Files 8-K

TL;DR

CPCI filed an 8-K on 4/2. Standard disclosure.

AI Summary

Catheter Precision, Inc. filed an 8-K on April 2, 2024, to report other events and financial statements. The company, formerly known as Ra Medical Systems, Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector.

Why It Matters

This filing indicates a routine update or event disclosure by Catheter Precision, Inc. to the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — This is a standard 8-K filing for 'Other Events' and does not appear to contain immediately concerning information.

Key Numbers

• 001-38677 — SEC File Number (Identifies the company's filing with the SEC)
• 38-3661826 — IRS Employer Identification No. (Company's tax identification number)

Key Players & Entities

• Catheter Precision, Inc. (company) — Registrant
• Ra Medical Systems, Inc. (company) — Former company name
• April 2, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 3841 (sic_code) — Standard Industrial Classification

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share VTAK NYSE American Indi

Filing Documents

• rmed_8k.htm (8-K) — 22KB
• rmed_ex231.htm (EX-23.1) — 2KB
• 0001654954-24-004187.txt ( ) — 146KB
• vtak-20240402.xsd (EX-101.SCH) — 6KB
• vtak-20240402_lab.xml (EX-101.LAB) — 14KB
• vtak-20240402_cal.xml (EX-101.CAL) — 1KB
• vtak-20240402_pre.xml (EX-101.PRE) — 9KB
• vtak-20240402_def.xml (EX-101.DEF) — 2KB
• rmed_8k_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events. On March 29, 2024, Catheter Precision, Inc. (the "Company") filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the "Form 10-K") with the Securities and Exchange Commission (the "SEC"). The Consent of Independent Registered Public Accounting Firm dated March 29, 2024 and filed as Exhibit 23.1 to the Form 10-K made reference to Registration Statement on Form S-3 333-269491, and to Registration Statement on Form S-3 Amendment No.1 No. 333-270919, instead of making reference to Registration Statements on Post-Effective Amendment No. 1 to Form S-3 on Form S-1 333-269491 and 333-270919. A new Consent of Independent Registered Public Accounting Firm, dated April 2, 2024 (the "Revised Consent"), has revised the references to such registration statements accordingly, is attached as Exhibit 23.1 to this Current Report on Form 8-K, and is hereby filed with the SEC. The Revised Consent does not change any previously reported financial results or other disclosure contained in the Form 10-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 23.1 Consent of WithumSmith+Brown, PC, Independent Registered Public Accounting Firm. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: April 2, 2024 By: /s/ Margrit Thomassen Margrit Thomassen Interim Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR